Forge Genetics

Executive Summary

Forge Genetics, founded in 2021 and based in London, UK, is a specialized biotechnology company offering world-leading expertise in engineering difficult-to-manipulate microbes, particularly Clostridia and other anaerobes. The company provides integrated services spanning strain development, advanced lab-scale fermentation (including gas fermentation), and metabolite analytics. This unique focus on recalcitrant organisms positions Forge Genetics at the forefront of industrial biotechnology, enabling the production of high-value chemicals, biofuels, and sustainable materials from non-food feedstocks and waste gases. With a strong emphasis on synthetic biology and AI-driven strain optimization, the company aims to accelerate the commercial adoption of anaerobic fermentation, which offers lower energy costs and the ability to utilize carbon-rich waste streams. While still in early stages of growth, Forge Genetics has the potential to become a key enabler for the bioeconomy, particularly in sectors like sustainable aviation fuel, bioplastics, and specialty chemicals. The company's service-based business model reduces capital intensity while generating revenue from diverse clients, from research institutions to industrial partners. As global demand for carbon-negative and circular economy solutions intensifies, Forge Genetics is well-positioned to capitalize on the growing need for efficient microbial chassis capable of converting waste gases into valuable products. However, the company faces competition from established synthetic biology firms and must demonstrate scalable, cost-competitive performance to attract major partnerships and funding.

Upcoming Catalysts (preview)

• Q4 2026Series A Funding Round60% success
• Q1 2027Strategic Partnership with a Major Chemical Company50% success
• Q3 2026Demonstration of High-Yield Gas Fermentation for Ethanol or Butanol55% success